Low cholesterol targets cut cardiovascular events by 33%
j / k
|
Down or up a comment |
h / l
|
Previous or next link |
?
|
This help |
70 mg/dL (the control) is around the 10th percentile.
IMO, surprising that reductions at the low end still seem to yield such large benefits. I'd expect it to saturate much earlier.
A 43-year study?! That would put the enrolment date starting in 1983, four years before the first clinically available statin.
The referenced study looked at cardiovascular endpoints at 3 years, not 43 years.
It's somewhat bombastic, but a really excellent book for overall "next generation" health.
not the problem in and of itself.
Mentioning this again: Cyclodextrin apparently effectively treats atherosclerosis and arteriosclerosis. [1][2]
[1] "AI analysis of CT scans finds 42.9% of patients have coronary inflammation" https://news.ycombinator.com/item?id=50202532 :
> Can Beta-Cyclodextrin treat (calcified) atherosclerotic plaques? And gout?
> What percentage of cardiovascular "plaque" is sugar alcohol and thus apparently treatable with β or α cyclodextrin, in controls and patients with conditions like Arteriosclerosis and Atherosclerosis?
[2] "Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming" (2016) https://www.science.org/doi/10.1126/scitranslmed.aad6100